Correction to: Scientific Reports https://doi.org/10.1038/s41598-026-36833-3, published online 27 January 2026

The original version of this Article contained an error in Figure 2, where the image for the shYTHDC1 group in the WERI‑RB‑1 cell invasion assay was inadvertently replaced with an incorrect image during figure preparation in label (E). This error resulted from mislabelling that caused confusion between images from two adjacent wells. The original Fig. 2 and accompanying legend appear below.

Fig. 2
Fig. 2The alternative text for this image may have been generated using AI.
Full size image

Downregulation of YTHDC1 enhances the proliferative and migratory abilities in RB cells. (A and B) qPCR and Western blot analyses of knockdown efficiency of two shRNAs targeting YTHDC1 in RB cell lines. (C and D) Cell proliferation was evaluated by CCK-8 (C) and EdU (D) assays. (E) Representative images (left) and quantification (right) of the transwell assays in RB cells. Scale bar: 25 μm. (F) Tumor volume and weight of subcutaneous tumors in xenograft models with YTHDC1 knockdown cells and controls (n = 5). Data are mean ± SD of three independent experiments. **p < 0.01, ***p < 0.001.

The original Article has been corrected.